Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions [EARLY_Phase 1]

View source ↗

Summary

This early phase 1 clinical trial evaluates the antimicrobial effect of calcium silicate and pectin as intracanal medications in teeth with necrosis and periapi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium Silicate (calcium silicate)
  • Pectin (pectin)

Snippet

Sponsor: Suez Canal University | Conditions: Asymptomatic Apical Periodontitis | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING